Cargando…
RETRACTED ARTICLE: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
The pandemic 2009 influenza A H1N1 virus is associated with significant mortality. Targeting S1PR1, which is known to modulate the immune response, provides protection against pathogenic influenza virus. The functional role and molecular mechanism of S1PR1 were analysed by generating inducible endot...
Autores principales: | Zhao, Jiangnan, Zhu, Meiying, Jiang, Hao, Shen, Simen, Su, Xin, Shi, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437142/ https://www.ncbi.nlm.nih.gov/pubmed/30918324 http://dx.doi.org/10.1038/s41598-019-41760-7 |
Ejemplares similares
-
Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2023) -
Author Correction: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2020) -
Retraction Note: Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study
por: Zhao, Jiangnan, et al.
Publicado: (2022) -
Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses
por: Jiang, Hao, et al.
Publicado: (2017) -
Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study
por: Zhao, Jiangnan, et al.
Publicado: (2020)